- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06663800
Additional Effects of Ujjayi Pranayama
October 28, 2024 updated by: Riphah International University
Additional Effects of Ujjayi Pranayama on Pulmonary Function in Post Coronary Artery Bypass Graft
Studying the impact of Ujjayi pranayama on post-Coronary Artery Bypass Grafting (CABG) patients has the potential to positively influence healthcare.
This research fosters a patient-centered approach, enhancing cardio respiratory function.
Patient education on these practices can empower individuals, actively contributing to their recovery and overall well-being.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
. Exercises such as Ujjayi pranayama lower heart rate and benefit high blood pressure sufferers.
To determine additional effects of Ujjayi pranayama on pulmonary function in post coronary artery bypass Graft (CABG).
Study Type
Interventional
Enrollment (Estimated)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Maria Razzaq, MSCPPT
- Phone Number: 03431597909
- Email: maria.razzaq@riphah.edu.pk
Study Contact Backup
- Name: Iqbal Tariq, MSCPPT
- Email: iqbal.tariq@riphah.edu.pk
Study Locations
-
-
Punjab
-
Rawalpindi, Punjab, Pakistan, 46060
- Railway General Hospital
-
Principal Investigator:
- Ume Kulsoom, MSCPPT
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Participants who have 1st post op Day
- Hemodynamically stable & well oriented patient
- Extubated Patient
- Voluntary based patients
- After approval of surgeon CABG patient were recruited
- Tachypnea
Exclusion Criteria:
- Hemodynamically unstable,
- Uncontrolled Hypertension,
- MSK disease,
- Any previous history of tuberculosis,
- Neurological disease ,
- Acute exacerbation of COAD & Asthma Attack,
- Any trauma, anxiety or Rib fracture case ,
- During surgery complaint of graft failure ,
- Unwilling to participate ,
- Postural Hypotension.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: arm:1 Pranayama
Arm:1 Additional effects of Ujjayi Pranayama
|
Inhale or breathe in slowly while taking a deep, prolonged breath through both nostrils.
As you inhale, attempt to tighten your throat and feel the air in your throat.
Air should not come into contact with the interior of the nose.
When air enters the throat, an odd sound is made.
Allow the breath to be loose and easy while you slightly tighten the back of your throat and hiss lightly as you breathe in and out.
The sound isn't forced, but it should be loud enough for someone to hear you if they were close.
Now close your right nostril and release the breath through your left.
As you exhale, try making the sound HHHHHAAAA
|
|
Other: arm: 2 (standard protocol)
Arm:2 (standard protocol)
|
Control Group will perform Deep Breathing Adhering to a FITT model protocol, with a frequency of 5 days.
Intensity set at 8 repetitions, duration range from 10 to 15 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Borg dyspnea
Time Frame: 5days
|
(Modified CR-10 is used to assess the degree of dyspnea, rated from 0 to 10. Zero means nothing at all, 0.5=extremely slight, 1=very slight, 2=slight, 3=moderate, 4=somewhat severe, 5=severe, 7=very severe, 9=extremely severe (almost maximal)
|
5days
|
|
PFT
Time Frame: 5days
|
Spirometer is simple test used to help diagnose and monitor certain lung conditions by measuring how much air you can breathe out in one forced breathe.
Which is a small machine attached by a cable to a mouthpiece.
This spirometer yielded generally reproducible results that were generally valid compared to laboratory-based spirometry.
The use of this handheld spirometer in clinical, occupational, and research settings seems justified
|
5days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiac monitors
Time Frame: 5days
|
After 5, 10, 15, 20, and 30 minutes of pranayama in the study group and without pranayama in the control group, recordings of HR, SBP, DBP, RR, SpO2
|
5days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Maria Razzaq, MsCPPT, Riphah International University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
October 28, 2024
Primary Completion (Estimated)
December 15, 2024
Study Completion (Estimated)
January 18, 2025
Study Registration Dates
First Submitted
October 23, 2024
First Submitted That Met QC Criteria
October 28, 2024
First Posted (Actual)
October 29, 2024
Study Record Updates
Last Update Posted (Actual)
October 29, 2024
Last Update Submitted That Met QC Criteria
October 28, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/MSPT0193 Kulsoom
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
maintaining confidentiality
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.